Clinical Trial Update: Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)

View source ↗

Summary

This clinical trial update investigates how quantitative anti-Ro52 antibody analysis may affect prognosis and patient stratification in Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Sjögren´s Syndrome | Status: NOT_YET_RECRUITING